tradingkey.logo
搜尋

EyePoint Pharmaceuticals Inc

EYPT
添加自選
12.190USD
-0.280-2.25%
收盤 07-24 16:00美東報價延遲15分鐘
1.01B總市值
虧損本益比TTM

股東統計

更新時間: 5月13日 週三
更新時間: 5月13日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Cormorant Asset Management, LP
9.86%
Suvretta Capital Management, LLC
9.34%
BlackRock Institutional Trust Company, N.A.
6.48%
Franklin Advisers, Inc.
5.89%
Federated Hermes Global Investment Management Corp.
5.74%
其他
62.70%
持股股東
持股股東
佔比
Cormorant Asset Management, LP
9.86%
Suvretta Capital Management, LLC
9.34%
BlackRock Institutional Trust Company, N.A.
6.48%
Franklin Advisers, Inc.
5.89%
Federated Hermes Global Investment Management Corp.
5.74%
其他
62.70%
股東類型
持股股東
佔比
Hedge Fund
37.20%
Investment Advisor
29.27%
Investment Advisor/Hedge Fund
29.25%
Private Equity
3.87%
Individual Investor
3.67%
Venture Capital
2.61%
Research Firm
2.18%
Bank and Trust
1.18%
Pension Fund
0.14%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
381
88.53M
105.59%
-2.75M
2025Q4
363
69.86M
126.07%
--
2025Q3
373
69.94M
127.01%
+1.23K
2025Q2
381
69.95M
127.71%
-5.27M
2025Q1
371
75.32M
126.89%
-11.89M
2024Q4
359
75.24M
109.81%
+11.20M
2024Q3
343
59.71M
126.62%
+193.11K
2024Q2
330
60.06M
120.79%
+1.75M
2024Q1
313
56.72M
108.78%
+2.51M
2023Q4
268
50.21M
76.86%
+16.41M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Cormorant Asset Management, LP
8.27M
9.91%
-60.00K
-0.72%
Dec 31, 2025
Suvretta Capital Management, LLC
7.83M
9.38%
+1.63M
+26.40%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
5.43M
6.51%
+1.15M
+26.73%
Dec 31, 2025
Franklin Advisers, Inc.
4.94M
5.92%
+798.84K
+19.31%
Dec 31, 2025
Federated Hermes Global Investment Management Corp.
4.81M
5.77%
+1.23M
+34.41%
Dec 31, 2025
Adage Capital Management, L.P.
4.70M
5.63%
-859.78K
-15.46%
Dec 31, 2025
Paradigm BioCapital Advisors LP
4.19M
5.02%
+500.79K
+13.57%
Feb 17, 2026
TCG Crossover Management, LLC
3.57M
4.28%
--
--
Dec 31, 2025
Janus Henderson Investors
2.94M
3.52%
+2.94M
--
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Virtus LifeSci Biotech Clinical Trials ETF
1%
Simplify Health Care ETF
0.99%
State Street SPDR S&P Pharmaceuticals ETF
0.98%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0.95%
Invesco Dorsey Wright SmallCap Momentum ETF
0.36%
Federated Hermes MDT Small Cap Core ETF
0.3%
iShares Micro-Cap ETF
0.15%
iShares Health Innovation Active ETF
0.15%
ProShares Ultra Nasdaq Biotechnology
0.12%
Invesco Nasdaq Biotechnology ETF
0.09%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
佔比1%
Simplify Health Care ETF
佔比0.99%
State Street SPDR S&P Pharmaceuticals ETF
佔比0.98%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比0.95%
Invesco Dorsey Wright SmallCap Momentum ETF
佔比0.36%
Federated Hermes MDT Small Cap Core ETF
佔比0.3%
iShares Micro-Cap ETF
佔比0.15%
iShares Health Innovation Active ETF
佔比0.15%
ProShares Ultra Nasdaq Biotechnology
佔比0.12%
Invesco Nasdaq Biotechnology ETF
佔比0.09%
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有